MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Galzin (zinc acetate)

Company: Teva Pharmaceutical
Approval Status: Approved January 1997
Treatment for: Wilson’s disease
Areas: Neurology & Nervous System; Pharmacology

| General Information |


General Information

Galzin has been approved for the treatment of Wilson's disease. Wilson’s disease is a potentially fatal inherited abnormality, occurring in one of 30,000 people, that causes excess copper to accumulate in the body, affecting the liver and the brain. Patients become ill as teenagers or as young adults with liver disease, often with neurologic symptoms. Galzin works by blocking absorption of copper from the intestine.




< back to top

Galzin Drug Information

The Galzin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.